Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Trial

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Type 2 Diabetes
  • Age: Between 18 - 99 Years
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Subjects who are 18 years of age or older
    2. Subjects who provide informed consent obtained before any study-related activities.
    3. Subjects with type 2 diabetes mellitus diagnosis
    4. Subjects who has been treated with either 1 or 2 oral antidiabetic medications
    5. Subjects who are current member of an Anthem affiliated commercial health plan with pharmacy benefits
    6. Subjects who has recorded glycosylated hemoglobin A1c (HbAlc) value within the last 90 days prior to randomization.
    7. Subjects who are able to Further intensify with an additional anti-diabetic oral or injectable medication is indicated to achieve glycemic target

You may not be eligible for this study if the following are true:

    1. Subjects who had previous randomization in this study
    2. Subjects who had rreatment with more than 2 oral antidiabetic medications or any injectable medication in a period of 30 days before the day of eligibility assessment.
    3. Subjects who had contraindications to semaglutide
    4. Female Subjects who is pregnant, breastfeeding or intends to become pregnant
    5. Subjects who are participating in another clinical trial

If you are registered as a volunteer, please login to the dashboard to send referrals.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.